Robuta

https://www.globenewswire.com/fr/news-release/2025/01/06/3004957/0/en/Revolution-Medicines-to-Present-at-43rd-Annual-J-P-Morgan-Healthcare-Conference.html Revolution Medicines to Present at 43rd Annual J.P. Morgan REDWOOD CITY, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel... revolution medicinesj ppresentannualmorgan https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/merck-no-longer-in-talks-to-buy-revolution-medicines/127566617 Merck Ends Acquisition Talks with Revolution Medicines Over Price Dispute, ETPharma Merck has halted negotiations to acquire Revolution Medicines, a move that follows challenges in agreeing on a price. This decision potentially paves the way... revolution medicinesmerckendsacquisitiontalks https://it.benzinga.com/quote/RVMD Revolution Medicines (RVMD) Prezzo delle Azioni, Quotazione, Notizie e Storico | Benzinga Ottieni il prezzo delle azioni in tempo reale di Revolution Medicines (RVMD), grafici, notizie e valutazioni degli analisti su Benzinga. Accedi a previsioni,... revolution medicinesrvmdprezzodelle https://revmedclinicaltrials.com/ Revolution Medicines - Clinical Trials Revolution Medicines is evaluating potential treatments for RAS mutant cancers through our clinical trials. Explore how you can participate or get involved. revolution medicinesclinicaltrials https://www.globenewswire.com/news-release/2026/04/17/3276479/0/en/Revolution-Medicines-Announces-Closing-of-Concurrent-Upsized-Public-Offerings-with-Aggregate-Gross-Proceeds-of-Approximately-2-2-Billion-Including-Full-Exercise-of-Underwriters-Opt.html Revolution Medicines Announces Closing of Concurrent REDWOOD CITY, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing... revolution medicinesannouncesclosingconcurrent https://jp.benzinga.com/quote/RVMD/report Revolution Medicines (RVMD) Stock Analysis Report | Financials & Insights Explore Revolution Medicines (RVMD) stock analysis with comprehensive data: access historical performance, financials, and insights. Updated May 2026 revolution medicinesstock analysisrvmdreportfinancials https://www.revmed.com/ Revolution Medicines Jan 13, 2025 - At Revolution Medicines our mission is to revolutionize treatment for patients with RAS-addicted cancers through targeted medicines. revolutionmedicines